Dr. Mischoulon is the Joyce Root Tedlow Professor of Psychiatry at Harvard Medical School, and Director of the Depression Clinical and Research Program (DCRP) at MGH. He graduated in 1994 from the MD-PhD program at Boston University School of Medicine, and completed his residency in adult psychiatry at MGH in 1998, serving as Chief Resident in Pscyhopharmacology.
Dr. Mischoulon's research has focused on various areas of depression, including psychopharmacology and complementary and alternative medicine. His research on omega-3 fatty acids has been funded my NARSAD, MCCAM/NCCIH, and the NIH. He mentors researchers from all over the world. He has published more than 300 articles, a textbook on natural medications, and a guide to treatments of depression. He has been an invited speaker at various sites around the country and internationally, and is a Distinguished Fellow of the American Psychiatric Association.
In addition to his research activities, Dr. Mischoulon teaches and supervises MGH/McLean psychiatry residents and Harvard medical students, and also lectures in various MGH/Harvard continuing medical education programs. He serves as Director of Training in the MGH Clinical Trials Network and Institute (CTNI), where he educates research clinicians on the proper administrative of diagnostic instruments in clinical trials. He also cares for patients through the DCRP clinical practice, and is regularly sought out for consultation regarding management of treatment-resistant depression and use of complementary therapies for psychiatric disorders.
If you are in crisis please dial 988 for the Suicide & Crisis Lifeline. Please note that ADAA is not a direct service organization. ADAA does not provide psychiatric, psychological, or medical advice, diagnosis, or treatment.
Founded in 1979, ADAA is an international nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, depression, OCD, PTSD, and co-occurring disorders through aligning research, practice and education.